title: Influence of bone marrow nucleated red blood cell dose on outcome after allogeneic haematopoietic stem cell transplantation.
authors.forename: Marie
authors.initials: M
authors.lastname: Robin
authors.forename: Solen
authors.initials: S
authors.lastname: Kernèis
authors.forename: Raphaël
authors.initials: R
authors.lastname: Porcher
authors.forename: Régis Peffault
authors.initials: RP
authors.lastname: de Latour
authors.forename: Richard
authors.initials: R
authors.lastname: Traineau
authors.forename: Patricia
authors.initials: P
authors.lastname: Ribaud
authors.forename: Vanderson
authors.initials: V
authors.lastname: Rocha
authors.forename: Agnès
authors.initials: A
authors.lastname: Devergie
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Marolleau
authors.forename: Marc
authors.initials: M
authors.lastname: Benburan
authors.forename: Gérard
authors.initials: G
authors.lastname: Socié
authors.forename: Jérôme
authors.initials: J
authors.lastname: Larghero
mesh_terms: D000293:Adolescent; D000328:Adult; D001854:Bone Marrow Cells / Q000166:cytology; D002648:Child; D004900:Erythroblasts / Q000637:transplantation*; D006085:Graft Survival; D006402:Hematologic Diseases / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D016896:Treatment Outcome